Alyeska Investment Group
COYA icon

Alyeska Investment Group’s Coya Therapeutics COYA Stock Holding History

Alyeska Investment Group’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15M Hold
800,000
– – 0.01% 522
2025
Q4 		$4.64M Buy
+800,000
New +$4.86M 0.01% 469

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group's COYA Position: Q1 2026 in Review

Alyeska Investment Group held its Coya Therapeutics (COYA) position steady in Q1 2026 at 800,000 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #522.

Alyeska Investment Group first reported a position in COYA in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.64M in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Alyeska Investment Group held 800,000 shares of Coya Therapeutics worth $3.15M as of Q1 2026.
  • Alyeska Investment Group left its Coya Therapeutics share count unchanged in Q1 2026.
  • Coya Therapeutics made up 0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #522 holding.
  • Alyeska Investment Group first reported a position in Coya Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Alyeska Investment Group's Coya Therapeutics position peaked at $4.64M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.